Rhino Ventures
1010 Raymur Ave, Vancouver, British Columbia, V6A 3T2, Canada
Overview
There is more to choosing an investor than selecting the term sheet with the highest valuation. Strategic capital, in its true form, extends the founding team’s capacity. That’s what we do at Rhino. We invest in companies where we can add tangible value. We’ve been on the other side of the table and appreciate the importance of funder and founder alignment. From startup, growth to exit; it is entrepreneurial ambition that drives value, not venture capitalists. We invest in individuals; trust and values fit are a centerpiece in every investment.
- Total investments
- 13
- Lead investments
- 7
- Investments · 12mo
- 1
- Active investors
- 7
Investment portfolio
- ShopVision
Participated · Seed · Sep 2025
ShopVision provides an intelligence and automation layer that helps brands and online retailers accelerate campaign planning, optimize pricing strategies, and improve overall performance through real-time insights and AI-powered workflows. The platform fuses competitive digital commerce datasets with the company’s own first-party data to surface actionable recommendations. Founded by Harry Chemko (CEO), Peter Sheldon (CPO), and Jeff Neil (CTO), the team focuses on enabling ecommerce operators to make faster, data-backed decisions. With its fresh capital, ShopVision plans to expand operations and accelerate product development. Although the company has not disclosed revenue or user metrics, management positions the product as a must-have tool for “high-velocity” ecommerce organizations. The newly secured funds are intended to support engineering hires and market expansion efforts.
- Aspect Biosystems
Participated · Series B · Jan 2025
Aspect Biosystems develops bioengineered cellular medicines and bioprinted tissue therapeutics aimed at restoring or supplementing biological functions, targeting serious metabolic and endocrine diseases including diabetes. Its platform integrates AI-powered bioprinting technology, stem cells, hypoimmune cell engineering and advanced biomaterials. The company has announced a partnership with Novo Nordisk to develop curative medicines for diabetes. Recent government funding (CA$79M federal and CA$23.8M provincial) is intended to support expansion, clinical development and biomanufacturing scale-up and to accelerate a path to commercialization. Aspect is positioning to deepen its platform capabilities and move its therapies toward patient impact.
- MyFO
Led · Seed · Oct 2024
MyFO is the fastest-growing platform for family offices and the wealth management professionals who service them, headquartered in Vancouver, BC. The company offers an omnipresent, end-to-end dashboard that consolidates data, documents, and stakeholder management and is integrated with over 20,000 financial institutions across North America. Core features include an intuitive user interface, analytics, scenario modeling, benchmarking, and advanced data-ingestion capabilities, all designed with an emphasis on security and privacy. The platform claims to reduce traditional client onboarding from as long as 18 months to just a few hours and highlights that only 16% of family offices currently use a data aggregation tool, underscoring market opportunity. MyFO plans to scale operations, enhance product offerings, and expand its team to meet growing demand in a family-office market managing roughly $5.9 trillion in assets. The company recently closed a Seed financing to support those growth plans.
- Ontopical
Led · Seed · Sep 2023
Ontopical is an AI-driven data and intelligence platform that helps businesses detect early signals from public sector data to win government work. Its platform mines millions of unstructured and multi-format public sector sources, including agendas, minutes, budgets and videos across cities, counties and school districts, to consolidate intelligence on upcoming contract opportunities and policy updates. Customers include large North American telecoms, major architecture, engineering and construction firms, energy and utilities providers, health services, software, IoT and technology companies, with more than half based in the U.S. Led by CEO Clayton Feick and based in Calgary, Ontopical raised a $3.3M seed extension and has now raised over $6M to date. The company will use the funds to further develop its AI-driven intelligence platform and expand across North America. Ontopical intends to triple its team over the next two years, hiring data engineers, data scientists, AI/ML specialists and sales and marketing staff, with the majority of roles based in Calgary.
- Twig Fertility
Led · Series A · Jun 2023
Twig Fertility operates a flagship midtown Toronto clinic, lab, and pharmacy that opened in 2022. The company was founded by President Tanner Kohara, CEO Zach Shapiro, and Medical Director Dr. Rhonda Zwingerman during Kohara's personal fertility journey. It offers in‑vitro fertilization, egg freezing, intrauterine insemination, LGBTQ2S+ family building, fertility checks, comprehensive reproductive genetic counselling, reproductive urology, and mental health and wellness support. Twig also created Fertility Check, a service for people curious about their fertility prior to family building. Its patient base includes heterosexual couples, same‑sex couples, elected single parents, and people seeking fertility preservation or fertility education, which the company groups as family builders, fertility preservers, and the fertility curious. Twig plans to use new funding to recruit and retain additional fertility specialists, develop its technology platform (including broadening AI capabilities and administrative tasks) to leverage personalized health and demographic data, and expand nationally to become a consistent, best‑in‑class reproductive health practice across Canada.